Werewolf Therapeutics, Inc. (HOWL) vs PDS Biotechnology Corporation (PDSB)

Werewolf Therapeutics, Inc. and PDS Biotechnology Corporation are both Biotechnology companies. Werewolf Therapeutics, Inc. and PDS Biotechnology Corporation are of similar size ($47.7M and $44.2M). PDS Biotechnology Corporation has the higher net margin (0.00% vs −141.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, PDS Biotechnology Corporation leads on 7 and Werewolf Therapeutics, Inc. on 5.

Valuation

Metric HOWL PDSB Biotechnology median
P/E n/m n/m 7.88
P/S 1.91 n/m 11.47
P/B 2.86 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 1.90 n/m 10.73
Earnings yield (76.04%) (80.00%) (28.84%)
Free cash flow yield (64.04%) (37.14%) (23.03%)

Profitability

Metric HOWL PDSB Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (128.18%) 0.00% 0.00%
Net margin (141.94%) 0.00% 0.00%
Free cash flow margin (122.51%) 0.00% 0.00%
Return on equity (119.86%) (543.97%) (57.72%)
Return on assets (59.31%) (136.65%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric HOWL PDSB Biotechnology median
Revenue growth (TTM) (5.21%) — 5.64%
EPS growth (last fiscal year) 18.40% 28.16% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HOWL PDSB Biotechnology median
Debt to equity 0.00 (1.21) 0.00
Current ratio 2.91 0.57 4.73
Net debt to EBITDA 0.97 0.50 0.96

Dividend

Metric HOWL PDSB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric HOWL PDSB Biotechnology median
Market cap 47.68m 44.21m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack